Table 2. Compounds significantly altered in obese versus nonobese ASCs.
Name | RT (min) | Experimental mass | Mass error (ppm) | p-value | Change Ob vs Nob [%] | RSD for Qcs[%] | Abundance* Ob | Abundance* Nob | |
---|---|---|---|---|---|---|---|---|---|
Mouse | Leukotriene-A4 | 4.11 | 340.2016 | 0 | 2.51E-03 | -35 | 6 | 5.8E+05 | 8.9E+05 |
Creatine | 0.27 | 131.0696 | 0 | 8.51E-05 | -60 | 2 | 1.7E+06 | 4.2E+06 | |
Human | Leukotriene-A4 | 4.11 | 340.2016 | 0 | 6.05E-03 | -65 | 6 | 1.4E+05 | 4.0E+05 |
Creatine | 0.27 | 131.0696 | 0 | 2.09E-02 | -24 | 2 | 1.4E+06 | 1.9E+06 |
*Total Abundance